Search

 

Drug Development for Stroke

WELCOME TO ACE THERAPEUTICS

We Are the Leading Preclinical CRO Company for Stroke

Ace Therapeutics is an innovative CRO company focusing in early drug discovery services from target validation to preclinical candidate identification and efficacy evaluation, with strong capabilities and technologies in the stroke field.

Our goal is to help pharmaceutical companies complete their research programs faster and more successfully, and find effective therapies for stroke.

About-img
OUR SERVICES

Pharmaceutical R&D for Stroke

Ace Therapeutics is committed to the preclinical phase of stroke drug development, covering everything from model construction, target identification to preclinical candidates and beyond with the flexibility required. We offer a broad portfolio of services and a global network of partners that enable us to provide end-to-end services for small molecule and biomolecule drug discovery in stroke.

Biomarker Identification and Screening Drug Efficacy Testing in Animal Models of Stroke Cell-based Assay Safety Assessment ADME DMPK Mechanism of Action Analysis Biophysical Analysis Medicinal Chemistry Integration Compound Screening Cascade Primary Screening Assay Development Protein Production Target Validation Preclinical Candidate Lead Optimization Hit-to-Lead Hit Identification Target Research
THERAPEUTIC AREAS

Explore Our Expertise in Preclinical Stroke Research

At Ace Therapeutics, we are dedicated to pushing the boundaries of scientific research and supporting drug development in multiple therapeutic areas within the field of preclinical stroke research.

Ischemic Stroke Research Services

We provide customized models, target identification, and drug efficacy assessment for ischemic stroke research to improve the understanding of the pathomechanisms of ischemic stroke and the development of therapeutics.

  • Thrombotic stroke
  • Embolic stroke
  • Cardioembolic stroke
  • Cryptogenic stroke
Hemorrhagic Stroke Research Services

Our approach enables the detection of nuanced responses in animal models, providing clear insight into the efficacy and safety of novel hemorrhagic stroke therapies.

  • Intracerebral hemorrhage
  • Subarachnoid hemorrhage
Transient Ischemic Attack (TIA) Research Services

Ace Therapeutics is equipped with advanced facilities and resources to support TIA research projects. We provide highly predictive TIA models, carefully executed assessments, and detailed observational measurements to determine the effects of your novel TIA therapy.

choose-img
WHY CHOOSE US

Grow Your Research With Experience

Ace Therapeutics has a proven, full-service model that has been delivering quality results for years, giving your stroke trial a competitive edge. The Ace Therapeutics team supports the development of therapeutics for the treatment of stroke through the use of our in-house resources including:

1

Professionals

Deep expertise and experience in vascular research and development.
2

Customization

Flexible approach with easy access to our global network of specialized laboratories. State-of-the-art technology provides you with a fully customized service.
3

Well-equipped

Our fully equipped laboratories have comprehensive capabilities from initial screening to candidate selection.
4

After Sales Service

Solving any problems or concerns that customers may have and ensuring the proper functioning of the product or service.
Ace Therapeutics Preclinical CRO for Stroke

We are committed to accelerating progress in stroke research and drug development.

Quick Links
Home Services Solutions
Resources About us Contact us Careers
Contact Us
Copyright © Ace Therapeutics. All rights reserved.
0
Inquiry Basket